Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Jan 18, 2018 04:07PM

Feb 21, 2018 11:38AM

Feb 21, 2018 05:45PM

Feb 21, 2018 05:52PM

Feb 22, 2018 10:34AM

fouremm

Feb 22, 2018 02:25PM

Re: AACR 2018

tada

Feb 23, 2018 02:54AM

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AACR 2018

in response to

Re: AACR 2018

fouremm

posted on Feb 23, 2018 11:14AM

"....Perhaps it is time to seriously consider the recombination of RVX and Zenith and pool all talent and financial resources...."

No thanks. Looks like a positive for RVX and a negative for ZEN to me.

3 Recommendations

Re: AACR 2018

narmac

Feb 23, 2018 12:41PM

Re: AACR 2018

fouremm

Feb 27, 2018 06:33PM

Re: AACR 2018

tada

Feb 27, 2018 08:43PM

Re: AACR 2018

KayakerBC